306:
226:
Croissant, Jonas; Maynadier, Marie; Gallud, Audrey; Peindy N'Dongo, Harmel; Nyalosaso, Jeff L.; Derrien, Gaëlle; Charnay, Clarence; Durand, Jean-Olivier; Raehm, Laurence; Serein-Spirau, Françoise; Cheminet, Nathalie; Jarrosson, Thibaut; Mongin, Olivier; Blanchard-Desce, Mireille; Gary-Bobo, Magali;
281:
347:
289:
210:
64:
227:
Garcia, Marcel; Lu, Jie; Tamanoi, Fuyuhiko; Tarn, Derrick; Guardado-Alvarez, Tania M.; Zink, Jeffrey I. (16 December 2013).
177:
340:
366:
371:
333:
258:
206:
200:
159:
110:
39:
317:
248:
240:
149:
141:
100:
24:
38:
Nanoimpellers for cancer drug delivery were first demonstrated in 2008. Initial work used
253:
228:
154:
129:
46:
mean this is not well suited for delivery in patients. Later work has shifted to using
360:
59:
47:
19:
are an experimental technology developed to eliminate some of the harmful effects of
20:
305:
31:-fighting drugs that only release their contents when hit by a specific type of
23:
by facilitating treatment of only specific areas of the body. Nanoimpellers are
128:
Lu, Jie; Choi, Eunshil; Tamanoi, Fuyuhiko; Zink, Jeffrey I. (31 March 2008).
262:
244:
163:
145:
114:
313:
43:
229:"Two-Photon-Triggered Drug Delivery in Cancer Cells Using Nanoimpellers"
105:
88:
130:"Light-Activated Nanoimpeller-Controlled Drug Release in Cancer Cells"
28:
32:
87:
Zheng, Yue Bing; Kiraly, Brian; Huang, Tony Jun (November 2010).
202:
Photochromic
Materials: Preparation, Properties and Applications
50:
light and two photon excitation (TPE) to trigger release.
42:, however the low penetration in tissue and potential for
321:
178:"Nanomachine Kills Cancer Cells With Exposure To Light"
89:"Molecular machines drive smart drug delivery"
341:
8:
82:
80:
348:
334:
252:
153:
104:
27:, light-activated containers filled with
233:Angewandte Chemie International Edition
76:
205:. John Wiley & Sons. p. 223.
199:Tian, He; Zhang, Junji (2016-06-14).
7:
302:
300:
282:"A Little Hope for Cancer Treatment"
320:. You can help Knowledge (XXG) by
14:
304:
65:Two-photon excitation microscopy
1:
180:. Inventorspot. 25 April 2008
280:Bullock, Dave (6 May 2008).
388:
299:
245:10.1002/anie.201308647
146:10.1002/smll.200700903
292:on 25 October 2012.
239:(51): 13813–13817.
106:10.2217/nnm.10.111
367:Radiation therapy
329:
328:
40:ultraviolet light
379:
350:
343:
336:
308:
301:
293:
288:. Archived from
267:
266:
256:
223:
217:
216:
196:
190:
189:
187:
185:
174:
168:
167:
157:
125:
119:
118:
108:
99:(9): 1309–1312.
84:
387:
386:
382:
381:
380:
378:
377:
376:
357:
356:
355:
354:
297:
279:
276:
271:
270:
225:
224:
220:
213:
198:
197:
193:
183:
181:
176:
175:
171:
127:
126:
122:
86:
85:
78:
73:
56:
12:
11:
5:
385:
383:
375:
374:
372:Oncology stubs
369:
359:
358:
353:
352:
345:
338:
330:
327:
326:
309:
295:
294:
275:
274:External links
272:
269:
268:
218:
211:
191:
169:
140:(4): 421–426.
120:
75:
74:
72:
69:
68:
67:
62:
55:
52:
13:
10:
9:
6:
4:
3:
2:
384:
373:
370:
368:
365:
364:
362:
351:
346:
344:
339:
337:
332:
331:
325:
323:
319:
316:article is a
315:
310:
307:
303:
298:
291:
287:
283:
278:
277:
273:
264:
260:
255:
250:
246:
242:
238:
234:
230:
222:
219:
214:
212:9783527683703
208:
204:
203:
195:
192:
179:
173:
170:
165:
161:
156:
151:
147:
143:
139:
135:
131:
124:
121:
116:
112:
107:
102:
98:
94:
90:
83:
81:
77:
70:
66:
63:
61:
60:Nanochemistry
58:
57:
53:
51:
49:
48:near infrared
45:
41:
36:
34:
30:
26:
22:
18:
17:Nanoimpellers
322:expanding it
311:
296:
290:the original
285:
236:
232:
221:
201:
194:
182:. Retrieved
172:
137:
133:
123:
96:
93:Nanomedicine
92:
37:
21:chemotherapy
16:
15:
361:Categories
71:References
25:nanoscale
314:oncology
263:24214916
184:30 March
164:18383576
115:21128714
54:See also
44:toxicity
254:3940420
155:2712492
261:
251:
209:
162:
152:
113:
29:cancer
312:This
286:Wired
134:Small
33:laser
318:stub
259:PMID
207:ISBN
186:2015
160:PMID
111:PMID
249:PMC
241:doi
150:PMC
142:doi
101:doi
363::
284:.
257:.
247:.
237:52
235:.
231:.
158:.
148:.
136:.
132:.
109:.
95:.
91:.
79:^
35:.
349:e
342:t
335:v
324:.
265:.
243::
215:.
188:.
166:.
144::
138:4
117:.
103::
97:5
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.